goBalto announced its latest release of goBalto Activate. The third major release of 2017 offers new features that further accelerate clinical study startup.
SSU is an array of activities performed at the outset of studies, including investigative site selection and initiation, regulatory document submission, contract and budget negotiations, and enrolling the first subject. The process of initiating clinical trials remains unwieldy, challenging, and often behind schedule, making SSU one of the poorest performing aspects of clinical trials. At a time when SSU remains a perpetual bottleneck, leading companies are positioning themselves ahead of the curve by embracing solutions that confront these real challenges, thereby emphasizing differentiation and operational efficiencies.
New APIs and functionality in the release allow for the exchange of alert or task information between Activate and the Shared Investigator Platform (SIP), and other industry site portals.
"The enterprise APIs enable other systems or transformation layers to interact with the application data in much the same way that a user would," said Sujay Jadhav, goBalto's CEO.
goBalto's integration points encompass the eClinical suite and business applications with key integration components (i.e., data staging, business rule compliance, target data staging and API processing) provided to ensure a seamless and successful integration.
The Configuration Designer functionality in Activate provides a self-service configuration wizard for workflows, providing the flexibility needed to rapidly respond to dynamic regulatory and SOP changes for studies, currently in-progress or planned.